Literature DB >> 23665502

Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses.

Kuan-Hui Hsu1, Richard C Fentzke, Anuj Chauhan.   

Abstract

Cystinosis is an inherited genetic disease characterized by the accumulation of cystine crystals in several tissues including the cornea. The corneal manifestations of cystinosis are treated by hourly instillation of cysteamine eye drops each day while awake. The high frequency of eye drop instillation along with the long duration of treatment leads to poor compliance in many patients. We have combined in vitro experiments with mathematical modeling to investigate the feasibility of daily use of cysteamine loaded contact lenses to replace the hourly instillation of drops. Our approach was based on incorporation of vitamin E diffusion barriers into commercially available contact lenses to increase the duration of drug release. Contact lenses were first soaked in a solution of vitamin E in ethanol. Subsequently, the lenses were soaked in an aqueous solution of cysteamine to load the drug. The drug release profiles from vitamin E treated lenses were measured under sink conditions. In addition, drug oxidation rates were measured after exposing drug loaded contact lenses to humidified room air. To study further the feasibility of using contact lenses for the delivery of cysteamine, a mass transfer model was used to determine the rates at which the drug loaded in the lens is delivered to the cornea. The results show that vitamin E loading increases the release duration from 10 min to about 3 h in solution, thus allowing the possibility of extended drug delivery. In addition to improving the release profiles, vitamin E loading also improved the drug stability by reducing the oxidation rates. The mathematical modeling of drug transport in the eye suggested that the vitamin E loaded contact lens can provide the daily therapeutic dose without causing toxicity, while significantly increasing the bioavailability compared to eye drops. Based on the in vitro experimental results and the mathematical modeling, it is likely that a single contact lens worn for about 2h could achieve the same therapeutic effects as hourly instillation of eye drops.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Contact lenses; Cysteamine; Cystinosis; Drug stability; Extended drug delivery; Vitamin E

Mesh:

Substances:

Year:  2013        PMID: 23665502     DOI: 10.1016/j.ejpb.2013.04.017

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  7 in total

1.  Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation.

Authors:  Phillip Dixon; Tanushri Ghosh; Kalyani Mondal; Aditya Konar; Anuj Chauhan; Sarbani Hazra
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  A sustained release cysteamine microsphere/thermoresponsive gel eyedrop for corneal cystinosis improves drug stability.

Authors:  Jorge Jimenez; Michael A Washington; Jayde L Resnick; Ken K Nischal; Morgan V Fedorchak
Journal:  Drug Deliv Transl Res       Date:  2021-02-04       Impact factor: 4.617

3.  In vivo drug delivery via contact lenses: The current state of the field from origins to present.

Authors:  Liana D Wuchte; Stephen A DiPasquale; Mark E Byrne
Journal:  J Drug Deliv Sci Technol       Date:  2021-02-18       Impact factor: 5.062

Review 4.  Treatment of corneal cystine crystal accumulation in patients with cystinosis.

Authors:  Fatemeh Shams; Iain Livingstone; Dilys Oladiwura; Kanna Ramaesh
Journal:  Clin Ophthalmol       Date:  2014-10-10

5.  Novel daily disposable therapeutic contact lenses based on chitosan and regenerated silk fibroin for the ophthalmic delivery of diclofenac sodium.

Authors:  Rachasit Jeencham; Manote Sutheerawattananonda; Saowaluk Rungchang; Waree Tiyaboonchai
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 6.  Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review.

Authors:  Achini K Makuloluwa; Fatemeh Shams
Journal:  Clin Ophthalmol       Date:  2018-01-24

Review 7.  Latest Clinical Approaches in the Ocular Management of Cystinosis: A Review of Current Practice and Opinion from the Ophthalmology Cystinosis Forum.

Authors:  Susmito Biswas; Martha Gaviria; Luísa Malheiro; João Pedro Marques; Vincenzo Giordano; Hong Liang
Journal:  Ophthalmol Ther       Date:  2018-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.